TA336004ARL17B antibody

Product: TA336004ARL17B antibody
Quantity: 50 µg
Synonyms: ADP-ribosylation factor 7 variant, ADP-ribosylation factor-like protein 17, ARL17A, ARL17P1
Presentation: Purified
Clonality: Polyclonal
Host: Rabbit
Isotype: IgG
CAS NO: 1173699-31-4 Product: AMG-337
Shipping to: Europe, USA/Canada
Immunogen: The immunogen for Anti-ARL17 Antibody: synthetic peptide directed towards the middle region of human ARL17. Synthetic peptide located within the following region: KCSHVEFGMWKGGRSHPFLPHSSRCAGSGGQLDSILPHQSPAWGPWGCKD.GeneID:100506084
Application: WB
Background: ARL17 is a GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. ARL17 is involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus.
Concentration:
Storage:
Buffer System: Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Preservatives:
State: Purified
Specifictiy:

Leave a Reply

TA336004ARL17B antibody

Product: TA336004ARL17B antibody
Quantity: 50 µg
Synonyms: ADP-ribosylation factor 7 variant, ADP-ribosylation factor-like protein 17, ARL17A, ARL17P1
Presentation: Purified
Clonality: Polyclonal
Host: Rabbit
Isotype: IgG
CAS NO: 1173699-31-4 Product: AMG-337
Shipping to: Europe, USA/Canada
Immunogen: The immunogen for Anti-ARL17 Antibody: synthetic peptide directed towards the middle region of human ARL17. Synthetic peptide located within the following region: KCSHVEFGMWKGGRSHPFLPHSSRCAGSGGQLDSILPHQSPAWGPWGCKD.GeneID:100506084
Application: WB
Background: ARL17 is a GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. ARL17 is involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus.
Concentration:
Storage:
Buffer System: Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Preservatives:
State: Purified
Specifictiy:

Leave a Reply